Australia is becoming one of the most promising centers of cannabis research. The University of Sidney in cooperation with Chris O’Brein Lifehouse recently started the world’s first clinical trial of treating cancer with cannabis. The trial is set to test the herb’s effects on vomiting and nausea caused by chemotherapy in eighty patients. Now, another group of researchers from Perth will study whether or not cannabis can help treat pancreatic cancer.
Pancreatic cancer is one of the most aggressive forms of cancer and is very difficult to treat. The disease is likely to replace the colorectal form of cancer as the second most common cancer death in just a couple of years. About eight percent of patients diagnosed with pancreatic cancer live longer than five years.
According to Perth News, the researchers from Curtin University are going to treat pancreatic cells cultured outside of the human body with a special combination of cannabis extracts. Scientists hope that the results of the new test will be similar to those of the recent studies on the influence of cannabis on breast cancer. Earlier research showed that THC, a major psychoactive compound found in cannabis, could reduce breast cancer tumors in laboratory rodents. Moreover, cannabis demonstrated the same efficiency as a chemotherapy drug Lapatinib.
The Curtin University research will include tests of the effects of cannabis alone and in combination with chemotherapy drugs. The University is currently working with Zelda Therapeutics, a big biopharmaceutical company from Perth. Both Zelda Therapeutics and Curtin University find the new research to be very promising and hope that it will open alternative therapies for treating pancreatic cancer.
Pre-clinical results of marijuana’s anti-cancer potential are amazing. Studies show that cannabis-based treatments may also have a positive impact on other pancreatic ailments.